Corient Private Wealth’s Guardant Health GH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.53M Buy
10,205
+280
+3% +$30.5K ﹤0.01% 1554
2026
Q1
$915K Buy
+9,925
New +$996K ﹤0.01% 1706
2023
Q4
– Sell
-15,613
Closed -$463K – 2282
2023
Q3
$463K Sell
15,613
-1,528
-9% -$53.7K ﹤0.01% 1539
2023
Q2
$614K Buy
+17,141
New +$492K ﹤0.01% 1353

Other funds holding GH

Corient Private Wealth's GH Position: Q2 2026 in Review

Corient Private Wealth increased its Guardant Health (GH) stake by 2.8% in Q2 2026, buying an estimated $30.5K and bringing the position to 10,205 shares worth $1.53M. The position accounts for ﹤0.01% of the portfolio, ranked #1554.

Corient Private Wealth first reported a position in GH in Q2 2023 and has held it in 4 quarters since. 601 funds tracked by Wall St. Rank hold GH as of Q2 2026.

  • Corient Private Wealth held 10,205 shares of Guardant Health worth $1.53M as of Q2 2026.
  • Corient Private Wealth bought 280 Guardant Health shares in Q2 2026, an estimated $30.5K.
  • Guardant Health made up ﹤0.01% of Corient Private Wealth's portfolio in Q2 2026, its #1554 holding.
  • Corient Private Wealth first reported a position in Guardant Health in Q2 2023 and has held it in 4 quarters since.
  • 601 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.

Based on Corient Private Wealth's 13F filing for Q2 2026, filed 12 Aug 2026.